23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.56%
Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-2.56%
Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
12.33%
EBIT growth exceeding 1.5x Insurance - Life median of 6.51%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
12.33%
Operating income growth 1.25-1.5x Insurance - Life median of 8.64%. Mohnish Pabrai would confirm if scale economies are a factor.
14.86%
Net income growth exceeding 1.5x Insurance - Life median of 8.90%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
14.83%
EPS growth exceeding 1.5x Insurance - Life median of 4.35%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
14.85%
Diluted EPS growth exceeding 1.5x Insurance - Life median of 4.35%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.66%
Negative OCF growth while Insurance - Life median is -13.22%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
107.68%
FCF growth of 107.68% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
20.67%
10Y revenue/share CAGR 75-90% of Insurance - Life median of 23.63%. John Neff would seek operational improvements to catch up with peers.
20.67%
5Y revenue/share growth near Insurance - Life median of 20.67%. Charlie Munger might see typical industry or economic growth patterns.
17.18%
3Y revenue/share growth near Insurance - Life median of 16.47%. Charlie Munger would note typical industry expansions over the short term.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.46%
Negative 3Y OCF/share CAGR while Insurance - Life median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
93.06%
Net income/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai would confirm that management’s capital allocation strategy drives the outperformance.
93.06%
5Y net income/share CAGR > 1.5x Insurance - Life median of 32.05%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
59.92%
3Y net income/share CAGR > 1.5x Insurance - Life median of 13.47%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.75%
3Y equity/share CAGR > 1.5x Insurance - Life median of 16.93%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.34%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
2.57%
Near Insurance - Life median. Charlie Munger considers it standard net worth compounding for the sector.
-2.15%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-0.36%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.